.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Queensland Health
Fish and Richardson
Cantor Fitzgerald
QuintilesIMS
Chinese Patent Office
Mallinckrodt
Express Scripts
Colorcon
Baxter

Generated: September 22, 2017

DrugPatentWatch Database Preview

LABETALOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Labetalol Hydrochloride, and what generic Labetalol Hydrochloride alternatives are available?

Labetalol Hydrochloride is a drug marketed by West-ward Pharms Int, Par Form, Sandoz, Allied Pharma Inc, Apothecon, Akorn Inc, Watson Labs, Sagent Agila Llc, Hospira, Baxter Hlthcare Corp, Ivax Sub Teva Pharms, Teva, and Gland Pharma Ltd. and is included in seventeen NDAs.

The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the labetalol hydrochloride profile page.

Summary for Tradename: LABETALOL HYDROCHLORIDE

Patents:0
Applicants:13
NDAs:17
Suppliers / Packagers: see list29
Bulk Api Vendors: see list53
Clinical Trials: see list2,306
Patent Applications: see list511
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LABETALOL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: LABETALOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-001Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075303-001May 28, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075133-003Aug 3, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075355-001Nov 29, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075113-003Aug 4, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Form
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL200908-003Jul 10, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075223-002Nov 20, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075239-001Nov 29, 1999APRXNoYes► Subscribe► Subscribe► Subscribe
Allied Pharma Inc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075215-001Jul 29, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Deloitte
Covington
Novartis
Teva
Boehringer Ingelheim
Moodys
McKesson
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot